Back to search

University of Patras

Διαφορική ρύθμιση της έκφρασης του γονιδίου της ιντερλευκίνης-2 και του ιού HIV-1 από μεταγραφικούς καταστολείς σε παρθενικά και μνημονικά Τ βοηθητικά λεμφοκύτταρα

Abstract

dc:description

IL-2 is the first cytokine produced when naive T helper (Th) cells are activated and differentiate into dividing pre-Th0 proliferating precursors. The HIV1 virus is transcriptionally active in activated CD4 T-cells, and inactive in naïve CD4 T-cells. IL-2 and HIV-1 expression is blocked in naive Th cells by a transcriptional silencer that binds to the ARRE-2/NFAT element of the IL-2 gene promoter and RATS-Repressor Activator Target Sequence of HIV1-LTR (-279 to -250bp). These two elements share a homologous sequence that encompasses the AAGGAG Εts-2 binding site. Herein we show that Ets-2 is the repressor of IL-2 and HIV-1-LTR expression in CD4+CD45RA+CD25-FoxP3- naive Th cells by binding to this common region. This silencing activity disappears in activated naïve Th cells and memory Th cells.We first measured the levels of ets-2 mRNA in activated with PMA/Ionomycin (P/I) or non activated (CM) peripheral blood-derived T-cells and 9 leukemic cell lines. Ets-2 mRNA was synthesized in T-cells and in the most cell lines when cultured in plain culture medium (CM), but its synthesis was severely reduced when the cells were stimulated. In naive Th cells, the ets-2 mRNA, quantity of Ets-2 protein and its binding activity to ARRE-2 and RATS sequence decrease upon Th cell activation, followed by a reciprocal expression of IL-2. Cyclosporine A stabilizes ets-2 mRNA and protein when the cells are activated.We transfected Jurkat cells with (i) the reporter plasmids IL-2-CAT, 4xARRE-CAT (4 copies of ARRE-2 sequence), 2xmutantARRE-CAT (carries a point mutation in the Ets-2 binding site) (ii) HIV1-LTR-CAT, 2xRATS-CAT (2 copies of RATS sequence), 2xmutantRATS-CAT (carries a point mutation in the Ets-2 binding site) and CMV-CAT (control), (iii) pCDNA3-ets2 (for ets-2 overexpression), (iv) ets-2 shRNA (to silence ets-2 expression in the cells). Co-transfection experiments in Jurkat cells with increasing amounts of pCDNA3-ets2, led to a gradual reduction of IL-2-CAT, 4xARRE-CAT, HIV1-LTR-CAT and 2xRATS-CAT transcriptional activity, upon cell stimulation with P/I, but not of CMV-CAT. No transcriptional response was observed for the 2xmutantARRE-CAT and 2xmutantRATS-CAT reporter genes. Cotransfection experiments with HIV1-LTR-CAT, 2xRATS-CAT and ets-2 shRNA led to an increase in both reporter genes activity but not for 2xmutantRATS-CAT and CMV-CAT. Also transfection of the Jurkat cell line with ets-2 shRNA clones led to a slight expression of endogenous IL- 2 mRNA confirming that Ets-2 acts as a repressor of IL-2 expression in these cells in non inductive conditions. Chromatin Imunoprecipitation experiments revealed that Ets-2 binding activity to the ARRE-2 element of the native IL-2 promoter is stronger in naive Th cells compared to activated or memory Th cells. In the same way when ChiP experiments performed in transfected with the HIV-1-LTR plasmid Jurkat cells, Ets-2 binding activity to the RATS element was stronger to the CM condition compared to the P/I where the Ets-2 binding activity disappears.In this work we suggest that ets-2 expression and protein binding to the ARRE-2 element of the IL-2 promoter are part of a strictly regulated process that results in a physiological transition of naive Th cells to Th0 cells upon antigenic stimulation. Malfunction of such a repression mechanism at the molecular level could lead to disturbed later events in Th cell plasticity, leading, in term, to autoimmune diseases or other pathological conditions. The transition of naive Th cells to memory and activated Th cells plays a crucial role in the activation of the HIV-1-LTR expression in the infected cells. Thus, our results also confirm the role of Ets-2 as a transcriptional repressor of HIV1. This HIV1-LTR-RATS-mediated repression may account for the low-level transcription and replication of HIV1 in naïve T-cells, and contribute to the viral latency and maintenance of viral reservoirs in patients, despite long-term therapy.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Panagoulias, Ioannis
  • Παναγούλιας, Ιωάννης

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37612

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Panagoulias, Ioannis; Παναγούλιας, Ιωάννης. Διαφορική ρύθμιση της έκφρασης του γονιδίου της ιντερλευκίνης-2 και του ιού HIV-1 από μεταγραφικούς καταστολείς σε παρθενικά και μνημονικά Τ βοηθητικά λεμφοκύτταρα. University of Patras, 2014. http://hdl.handle.net/10442/hedi/37612